This signaling axis is negatively regulated by PTEN, a tumor-suppressor phosphatase that dephosphorylates PIP3 back to PIP2, thereby restraining Akt activation and maintaining signaling balance [37]. The gene discussed is AKT1; the disease is neoplasm.